The Food and Drug Administration (FDA) approved a new medication on Monday for Alzheimer’s disease despite questions about its effectiveness from experts. Aducanumab, or its brand name Aduhelm, is the first Alzheimer’s drug to be approved by the FDA in 18 years. This medication is a monthly intravenous infusion intended to slow cognitive decline in… Continue Reading